Clicky

VBI Vaccines Inc.(VBIV)

Description: VBI Vaccines Inc., a biotechnology company, engages in the formulation, development, and delivery of vaccines. It develops Thermostable IM flu vaccine for the needs of pediatric, adult, and geriatric markets; Thermostable IM measles vaccines; Thermostable Oral flu and Shigella vaccines; prophylactic VLP-based vaccines to prevent cytomegalovirus infections and diseases; and seasonal/pandemic influenza vaccines. The company serves customers in the United States and internationally. VBI Vaccines Inc. was formerly known as Variation Biotechnologies (US), Inc. The company was founded in 2001 and is based in Cambridge, Massachusetts with research facilities in Ottawa, Canada.


Keywords: Medicine Biotechnology Disease Vaccines Influenza Vaccination Virology Influenza Vaccine Measles Cytomegalovirus Infection Cytomegalovirus Infections Seasonal/Pandemic Influenza Shigella

Home Page: www.vbivaccines.com

VBIV Technical Analysis

160 Second Street
Cambridge, MA 02142
United States
Phone: 617 830 3031


Officers

Name Title
Mr. Jeffery R. Baxter F.C.M.A., FCMA Pres, CEO & Director
Mr. Christopher McNulty CFO, Head of Bus. Devel. & Director
Dr. David Evander Anderson Chief Scientific Officer
Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. Chief Medical Officer
Nicole Anderson Director of Corp. Communications & Investor Relations
Ms. Athena Kartsaklis Sr. VP of Fin., Chief Compliance Officer & Principal Financial Officer
Ms. Nell Beattie Chief Bus. Officer
Mr. Avi Mazaltov Global Head of Manufacturing & GM of SciVac
Mr. Misha Nossov Sr. VP of Global Commercial Supply Strategy & Head of Europe
Mr. T. Adam Buckley Sr. VP of Bus. Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.5634
Price-to-Sales TTM: 139.5181
IPO Date: 1995-08-18
Fiscal Year End: December
Full Time Employees: 149
Back to stocks